It has been found that cisplatin can up-regulate MHCI on the surface of head and neck cancer cells and enhance the presentation of tumor antigens, thus promoting the recognition of tumor cells by CTL and the activation of CD8+T cells (Gameiro et al., 2012; Tran et al., 2017; Lin et al., 2021b). Here, CD8A is linked to neoplasm.